Ligand Pharmaceuticals | LGND - Current Liabilities



Ligand Pharmaceuticals reported $64.73M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Amgen USD 20.48B 2.53B Jun/2025
Arrowhead Research USD 194.53M 26.01M Jun/2025
Baxter International USD 3.48B 3.03B Mar/2025
Bristol-Myers Squibb USD 27.53B 3.46B Jun/2025
Eli Lilly USD 39.02B 8.95B Jun/2025
Gilead Sciences USD 11.19B 1.15B Jun/2025
GlaxoSmithKline GBP 20.38B 453M Jun/2025
Glaxosmithkline GBP 20.38B 1.32B Jun/2025
Insmed USD 311.68M 72.45M Jun/2025
Ionis Pharmaceuticals USD 897.24M 646.94M Jun/2025
Ligand Pharmaceuticals USD 64.73M 6.05M Jun/2025
MacroGenics USD 39M 16.53M Jun/2025
Merck USD 26.04B 863M Jun/2025
Pacira USD 313.16M 1.57M Jun/2025
Pfizer USD 37.73B 1.27B Jun/2025
Veracyte USD 76.43M 1.31M Jun/2025